Immunai
Immunai is a biotech company that combines single cell genomics with ML algorithms to enable high resolution profiling of the immune system.
Total raised
€19M
€18,506,000
Funding rounds
1
Investors
2
distinct backers
Active since
2020-05
latest 2020-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-14 | Seed | €19M | TLV Partners,Viola Group | View deal → |
Investors
2Related news
Similar companies
same sector or country- Mistral AI€3.5BFrance · AI
- UiPath€1.7BRomania · AI
- Helsing€1.4BGermany · AI
- ElevenLabs€1.2BUK · AI
- Ineffable Intelligence€940MUK · AI
- Advanced Machine Intelligence (AMI)€885MFrance · AI